CIZZLE BIOTECHNOLOGY HOLDINGS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.7 GBX | +6.25% |
|
+17.24% | -12.82% |
| 06-17 | Cizzle says CIZ1B biomarker test picked for "major" US cancer study | AN |
| 04-30 | EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 8.51M | - | - | - | - | - | |
| 51.12B | - | |||||
| 39.4B | ||||||
| 38.48B | ||||||
| 26.36B | ||||||
| 26.22B |
